Swiss drugmakers face US pricing trade pressure
Switzerland's pharmaceutical sector is facing the prospect of a US trade investigation, with Interpharma — the Swiss pharmaceutical industry body — warning on 26 June that the country could be targeted over its drug pricing and reimbursement practices.











